PMID- 34554759 OWN - NLM STAT- MEDLINE DCOM- 20220225 LR - 20220531 IS - 1535-3907 (Electronic) IS - 1535-3893 (Linking) VI - 20 IP - 11 DP - 2021 Nov 5 TI - Matrix and Sampling Effects on Quantification of Protein Biomarkers of Drug-Induced Liver Injury. PG - 4985-4994 LID - 10.1021/acs.jproteome.1c00478 [doi] AB - Macrophage colony stimulating factor 1 receptor (MCSF1R), osteopontin (OPN), high-mobility group protein B1 (HMGB1), glutamate dehydrogenase (GLDH), keratin 18 (K18), and caspase-cleaved keratin 18 (ccK18) are considered promising mechanistic biomarkers for the diagnosis of drug-induced liver injury. Here, we aim to elucidate the impact of the sample matrix and handling on the quantification of these emerging protein biomarkers. We investigated effects such as time from collection to centrifugation during serum (+/- gel) or EDTA plasma preparation on two assay platforms: immunoaffinity liquid chromatography mass spectrometric assays and sandwich immunoassays. Furthermore, we measured GLDH activity with an enzymatic activity assay. Matrix effects were observed particularly for HMGB1 and MCSF1R. HMGB1 levels were higher in serum than in plasma, whereas higher concentrations of MCSF1R were observed in plasma than in serum. A comparison of sample collection to centrifugation time ranging from 15 to 60 min demonstrated increasing levels of HMGB1 in serum, while MCSF1R, OPN, GLDH, and ccK18 concentrations remained stable. Additionally, there was a poor correlation in HMGB1 and ccK18 levels between serum and plasma. Considering the observed matrix effects, we recommend plasma as a matrix of choice and cross-study comparison studies to be limited to those using the same matrix. FAU - Anselm, Viktoria AU - Anselm V AD - SIGNATOPE GmbH, Reutlingen 72770, Germany. FAU - Sommersdorf, Cornelia AU - Sommersdorf C AD - SIGNATOPE GmbH, Reutlingen 72770, Germany. FAU - Carrasco-Triguero, Montserrat AU - Carrasco-Triguero M AD - Genentech, San Francisco, California 94080, United States. FAU - Katavolos, Paula AU - Katavolos P AD - Genentech, San Francisco, California 94080, United States. AD - Bristol-Myers Squibb, New Brunswick, New Jersey 08901, United States (at Genentech during the conduct of this study). FAU - Planatscher, Hannes AU - Planatscher H AD - SIGNATOPE GmbH, Reutlingen 72770, Germany. FAU - Steinhilber, Andreas AU - Steinhilber A AD - SIGNATOPE GmbH, Reutlingen 72770, Germany. FAU - Joos, Thomas AU - Joos T AD - SIGNATOPE GmbH, Reutlingen 72770, Germany. AD - NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen 72770, Germany. FAU - Poetz, Oliver AU - Poetz O AUID- ORCID: 0000-0002-1189-9547 AD - SIGNATOPE GmbH, Reutlingen 72770, Germany. AD - NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen 72770, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210923 PL - United States TA - J Proteome Res JT - Journal of proteome research JID - 101128775 RN - 0 (Biomarkers) RN - 0 (HMGB1 Protein) RN - 0 (HMGB1 protein, human) RN - 0 (Keratin-18) RN - 0 (Proteins) RN - 0 (SPP1 protein, human) RN - 106441-73-0 (Osteopontin) RN - EC 1.4.1.2 (Glutamate Dehydrogenase) RN - EC 2.7.10.1 (Receptor, Macrophage Colony-Stimulating Factor) SB - IM MH - Biomarkers MH - *Chemical and Drug Induced Liver Injury/diagnosis MH - Glutamate Dehydrogenase MH - HMGB1 Protein MH - Humans MH - Keratin-18 MH - Osteopontin MH - Proteins MH - Receptor, Macrophage Colony-Stimulating Factor MH - Specimen Handling OTO - NOTNLM OT - centrifugation OT - drug-induced liver injury OT - immunoassay OT - mass spectrometry OT - plasma OT - preanalytical effects OT - serum OT - serum gel EDAT- 2021/09/24 06:00 MHDA- 2022/02/26 06:00 CRDT- 2021/09/23 17:13 PHST- 2021/09/24 06:00 [pubmed] PHST- 2022/02/26 06:00 [medline] PHST- 2021/09/23 17:13 [entrez] AID - 10.1021/acs.jproteome.1c00478 [doi] PST - ppublish SO - J Proteome Res. 2021 Nov 5;20(11):4985-4994. doi: 10.1021/acs.jproteome.1c00478. Epub 2021 Sep 23.